Key cold chain for medical research Living with AIDS # 411
Bio-banking is a novel concept on the African continent and South Africa is the first country to introduce it.
‘Bio-banking is being able to maintain the retention of samples into the future. Sometimes you don’t know how long you’re going to need the samples for. You might need them in two years’ time, six months’ time, and sometimes, up to 5, 10 or 15 years’ times when a test may come up that you can use the sample for. And bio-banking is being able to ensure that the integrity of the samples is kept so that when you do run the test, you’re able to get sense out of the result’, explained Dr Jessica Trusler, Medical Director of Bio-analytical Research Corporation (BRAC) South Africa.
Situated down the road from the Johannesburg Country Club in Auckland Park, the facility is state-of-the-art technology that requires extremely cold temperatures for it to function. It’s designed to store more than two million clinical trial samples in -80 degree Celsius freezer storage and liquid nitrogen.
‘Depending on the type of samples, samples can be kept at -80 degree Celsius for 5 ‘ 10 years if they are plasma or serum. But if they are cells, they actually need to be kept in liquid nitrogen and that almost keeps them hovering alive for future use and that’s below -150 down to -196 degree Centigrade’, Dr Trusler said.
These very cold storage conditions need to be maintained at all times to ensure that the samples retain their quality for research purposes.
‘Our normal deep freeze in your kitchen goes down to -20 degrees if you’ve got a chest deep freeze. The bottom of your fridge doesn’t normally go below about to -10. So, here we’re talking -70, -80 and then the liquid nitrogen goes down to -196. It’s so cold that you can’t imagine it. If you put a banana in liquid nitrogen it would freeze within two seconds and it would crack open’ she said.
‘We really do have first-class facilities. We will ensure that every sample counts and that going forward we will be able to maintain the cold chain at all points so that if that sample is the one that will find a cure for AIDS, for TB, for whatever disease there is in the future, the sample will be able to be kept in South Africa’¦ here’¦ for our people’, she continued.
‘The ability to store samples long term, including the RNA and DNA of these infectious pathogens means that we can do things like look at resistance patterns to drugs, we can use the DNA in the future for vaccine development, we can store TB DNA looking at resistance patterns against the various drugs and the role of what we call MOTTS, the non-tuberculous organisms in the immuno-compromised patients. So, there’s a lot of unique stuff that we can do here’, added Dr Peter Cole, Chief Executive Officer of Bio-analytical Research Corporation South Africa.
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Key cold chain for medical research Living with AIDS # 411
by Health-e News, Health-e News
November 5, 2009